Cary-based Chiesi USA continues to expand its diversity, equity and inclusion efforts through partnerships and research funding that directly support North Carolina students and researchers.
Read More
Adults living with cystic fibrosis (CF) now have access to a new revolutionary therapy aimed at improving pulmonary function. Here are the details.
Read More
Chiesi USA has announced the appointment of Jon Zwinski as General Manager and Chief Executive Officer of Chiesi USA to advance the company’s global therapeutic efforts. Here are the details.
Read More
Chiesi USA (pronounced, the American subsidiary of family-owned Chiesi Farmaceutici of Parma, Italy, is updating its five-year strategic plan and expects robust growth in U.S revenues over the next decade.
Read More
Chiesi USA of Cary and its European partner Holostem Terapie Avanzate have received Orphan Drug Designation from the U.S. Food and Drug Administration for an investigational cell-based therapy for a rare eye disease.
Read More
